- Home
- ABVX vs NUS Comparison
ABVX vs NUS Comparison
Compare ABVX & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVX
- NUS
- Stock Information
- Founded
- ABVX 2013
- NUS 1984
- Country
- ABVX France
- NUS United States
- Employees
- ABVX N/A
- NUS N/A
- Industry
- ABVX
- NUS Other Pharmaceuticals
- Sector
- ABVX
- NUS Health Care
- Exchange
- ABVX Nasdaq
- NUS Nasdaq
- Market Cap
- ABVX 511.3M
- NUS 440.8M
- IPO Year
- ABVX N/A
- NUS 1996
- Fundamental
- Price
- ABVX $66.49
- NUS $8.75
- Analyst Decision
- ABVX Buy
- NUS Hold
- Analyst Count
- ABVX 7
- NUS 2
- Target Price
- ABVX $65.71
- NUS $6.88
- AVG Volume (30 Days)
- ABVX 2.8M
- NUS 497.0K
- Earning Date
- ABVX 08-11-2025
- NUS 08-07-2025
- Dividend Yield
- ABVX N/A
- NUS 2.74%
- EPS Growth
- ABVX N/A
- NUS N/A
- EPS
- ABVX N/A
- NUS N/A
- Revenue
- ABVX $11,444,012.00
- NUS $1,679,268,000.00
- Revenue This Year
- ABVX $284.20
- NUS N/A
- Revenue Next Year
- ABVX N/A
- NUS N/A
- P/E Ratio
- ABVX N/A
- NUS N/A
- Revenue Growth
- ABVX 128.98
- NUS N/A
- 52 Week Low
- ABVX $4.77
- NUS $5.32
- 52 Week High
- ABVX $72.90
- NUS $11.64
- Technical
- Relative Strength Index (RSI)
- ABVX 92.92
- NUS 52.51
- Support Level
- ABVX $9.96
- NUS $8.16
- Resistance Level
- ABVX $72.90
- NUS $9.82
- Average True Range (ATR)
- ABVX 1.84
- NUS 0.39
- MACD
- ABVX 6.88
- NUS -0.02
- Stochastic Oscillator
- ABVX 90.17
- NUS 37.79
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.